Terms: = Bone cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Clinical Outcome
7 results:
1. The Terry Fox Research Institute Canadian Prostate cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation.
Ouellet V; Aprikian A; Bergeron A; Brimo F; Bristow RG; Chevalier S; Drachenberg D; Fazli L; Fleshner NE; Gleave M; Karakiewicz P; Klotz L; Lacombe L; Lattouf JB; van der Kwast T; Squire JA; Latour M; Trudel D; Mes-Masson AM; Saad F
BMC Urol; 2018 Sep; 18(1):78. PubMed ID: 30200929
[TBL] [Abstract] [Full Text] [Related]
2. EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth.
Perurena N; Zandueta C; Martínez-Canarias S; Moreno H; Vicent S; Almeida AS; Guruceaga E; Gomis RR; Santisteban M; Egeblad M; Hermida J; Lecanda F
J Hematol Oncol; 2017 Jan; 10(1):23. PubMed ID: 28103946
[TBL] [Abstract] [Full Text] [Related]
3. Predictive efficacy of the 2014 International Society of Urological Pathology Gleason grading system in initially diagnosed metastatic prostate cancer.
Sun GX; Shen PF; Zhang XM; Gong J; Gui HJ; Shu KP; Liu JD; Zhao J; Yang YJ; Chen XQ; Chen N; Zeng H
Asian J Androl; 2017; 19(5):573-578. PubMed ID: 27569001
[TBL] [Abstract] [Full Text] [Related]
4. clinical outcome of hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL): experience from a single institution.
Doki N; Ohashi K; Oshikawa G; Kobayashi T; Kakihana K; Sakamaki H
Pathol Oncol Res; 2014 Jan; 20(1):61-6. PubMed ID: 23821455
[TBL] [Abstract] [Full Text] [Related]
5. Cribriform-morular variant of papillary thyroid carcinoma displaying poorly differentiated features.
Nakazawa T; Celestino R; Machado JC; Cameselle-Teijeiro JM; Vinagre J; Eloy C; Benserai F; Lameche S; Soares P; Sobrinho-Simões M
Int J Surg Pathol; 2013 Aug; 21(4):379-89. PubMed ID: 23349472
[TBL] [Abstract] [Full Text] [Related]
6. Haploidentical bone marrow transplants for haematological malignancies using non-myeloablative conditioning therapy and post-transplant immunosuppression with cyclophosphamide: results from a single Australian centre.
Bilmon IA; Kwan J; Gottlieb D; Kerridge I; McGurgan M; Huang G; George B; Hertzberg M; Bradstock KF
Intern Med J; 2013 Feb; 43(2):191-6. PubMed ID: 22646924
[TBL] [Abstract] [Full Text] [Related]
7. Impact of disseminated tumor cells in bone marrow at diagnosis in patients with nonmetastatic prostate cancer treated by definitive radiotherapy.
Berg A; Berner A; Lilleby W; Bruland ØS; Fosså SD; Nesland JM; Kvalheim G
Int J Cancer; 2007 Apr; 120(8):1603-9. PubMed ID: 17230512
[TBL] [Abstract] [Full Text] [Related]
